SCHEMBL2302761

SCHEMBL2302761

FC(F)(F)CCOCC1CO1

nearest known ligand 0.58

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.58
SMN1; SMN2 Q16637 2/20 0.50
ALDH1A1 P00352 6/20 0.47
TDP1 Q9NUW8 2/20 0.47
MAPK1 P28482 1/20 0.47
TP53 P04637 3/20 0.31
MAPT P10636 2/20 0.31
HPGD P15428 2/20 0.31
HIF1A Q16665 2/20 0.31
MEN1 O00255 1/20 0.31
CYP1A2 P05177 1/20 0.31
KMT2A Q03164 1/20 0.31
PPARG P37231 1/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10036677 0.88 TSHR (0.65) TSHRSMN1; SMN2ALDH1A1TDP1MAPK1
SCHEMBL28577245 0.85 TSHR (0.52) TSHRSMN1; SMN2ALDH1A1TDP1MAPK1
SCHEMBL19615496 0.80 TSHR (0.46) TSHRSMN1; SMN2ALDH1A1TDP1MAPK1
SCHEMBL24388690 0.79 TSHR (0.48) TSHRSMN1; SMN2ALDH1A1TDP1MAPK1
SCHEMBL14961438 0.79 LMNA (0.40) TSHRSMN1; SMN2ALDH1A1TDP1
SCHEMBL4298953 0.78 TSHR (0.58) TSHRSMN1; SMN2ALDH1A1TDP1MAPK1
SCHEMBL16684221 0.78 TSHR (0.79) TSHRSMN1; SMN2ALDH1A1TDP1MAPK1
SCHEMBL22418810 0.78 TSHR (0.79) TSHRSMN1; SMN2ALDH1A1TDP1MAPK1
SCHEMBL17197994 0.78 TSHR (0.79) TSHRSMN1; SMN2ALDH1A1TDP1MAPK1
SCHEMBL20094 0.78 TSHR (0.79) TSHRSMN1; SMN2ALDH1A1TDP1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090264572-A1 COATING COMPOSITIONS AND USES THEREOF ETERNAL CHEMICAL CO., LTD. (TW) 2009-10-22 US claimed
CN-103613974-A Coating composition and use thereof ETERNAL CHEMICAL CO LTD 2014-03-05 CN disclosed
US-8088566-B2 Photoresists; using compound containing an orgaooxygen or organosulfur compound FUJIFILM CORPORATION (JP) 2012-01-03 US disclosed
US-7989581-B2 Polyether from ring-opening of glycidyl ether with (C2-C5 alkylene oxide) monohydric alcohol DOW CORNING TORAY COMPANY, LTD. (JP) 2011-08-02 US disclosed
US-7846587-B2 noncrystalline fluorine containing polyethers; perfluoropolyethers; high molecular weight, high ionic conductivity at room temperature, low viscosity, nonflammable, oxidation resistance; for use as electrolyte of lithium secondary batteries, capacitors, and solar cells DAIKIN INDUSTRIES, LTD. (JP) 2010-12-07 US disclosed
US-20100022732-A1 Polyether And Method For Producing The Same DOW CORNING TORAY COMPANY, LTD. (JP) 2010-01-28 US disclosed
CN-101565573-A Coating composition and use thereof ETERNAL CHEMICAL CO LTD (CN) 2009-10-28 CN disclosed
US-20090264572-A1 COATING COMPOSITIONS AND USES THEREOF ETERNAL CHEMICAL CO., LTD. (TW) 2009-10-22 US disclosed
EP-2022808-A1 POLYETHER AND METHOD FOR PRODUCING THE SAME Dow Corning Toray Co., Ltd. (JP) 2009-02-11 EP disclosed
US-20080241742-A1 SURFACE-TREATING AGENT FOR PATTERN FORMATION AND PATTERN-FORMING METHOD USING THE SURFACE-TREATING AGENT FUJIFILM CORPORATION (JP) 2008-10-02 US disclosed
US-20080020275-A1 noncrystalline fluorine containing polyethers; perfluoropolyethers; high molecular weight, high ionic conductivity at room temperature, low viscosity, nonflammable, oxidation resistance; for use as electrolyte of lithium secondary batteries, capacitors, and solar cells DAIKIN INDUSTRIES, LTD. (JP) 2008-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080241742-A1 SURFACE-TREATING AGENT FOR PATTERN FORMATION AND PATTERN-FORMING METHOD USING THE SURFACE-TREATING AGENT KRT18, FSCN1, SLC11A2 TSHR 1294/4885SMN1; SMN2 1897/4885ALDH1A1 445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.